Literature DB >> 8389178

The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991.

D H Van Thiel1, B Carr, S Iwatsuki, R R Selby, J J Fung, T E Starzl.   

Abstract

Experience with liver transplantation over a period of 11 years at the University of Pittsburgh is presented. The application of liver transplantation to cases of hepatocellular carcinoma has changed considerably over this 11-year period with the sequential introduction of adjuvant and, more recently, neoadjuvant chemotherapy. Results with the combination of chemotherapy plus surgery appear to be better than results with either agent alone. Moreover, the early results with neoadjuvant therapy appear to be better than those achieved with adjuvant therapy. As a result of this experience, conceptual changes in the approach to the problem of hepatic cancer and the role of both chemotherapy and liver transplantation in its management have changed at the University of Pittsburgh. These changes are identified and discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8389178      PMCID: PMC2977953          DOI: 10.1002/jso.2930530522

Source DB:  PubMed          Journal:  J Surg Oncol Suppl        ISSN: 1046-7416


  8 in total

Review 1.  Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

Authors:  T E Starzl; B J Zitelli; B W Shaw; S Iwatsuki; J C Gartner; R D Gordon; J J Malatuck; I J Fox; A H Urbach; D H Van Thiel
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

Review 2.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

Review 3.  Liver transplantation (2).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

Review 4.  Liver transplantation: an overview.

Authors:  W C Maddrey; D H Van Thiel
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

5.  A liver transplant center information management system.

Authors:  R D Gordon; B Markus; S Mitchell
Journal:  Gastroenterol Clin North Am       Date:  1988-03       Impact factor: 3.806

6.  Analysis of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

7.  Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: clinicopathological study of resection or transplantation.

Authors:  L Belli; F Romani; L S Belli; L De Carlis; G Rondinara; F Baticci; E Del Favero; E Minola; F Donato; V Mazzaferro
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

8.  Hepatic resection versus transplantation for hepatocellular carcinoma.

Authors:  S Iwatsuki; T E Starzl; D G Sheahan; I Yokoyama; A J Demetris; S Todo; A G Tzakis; D H Van Thiel; B Carr; R Selby
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

  8 in total
  14 in total

1.  Historical perspective on the importance of the Milan criteria.

Authors:  J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

2.  Transarterial chemoembolization in the treatment of hepatoblastoma in children.

Authors:  Thomas J Vogl; Albert Scheller; Ursula Jakob; Stefan Zangos; Medhat Ahmed; Mohamed Nabil
Journal:  Eur Radiol       Date:  2005-07-08       Impact factor: 5.315

3.  Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.

Authors:  P E Majno; R Adam; H Bismuth; D Castaing; A Ariche; J Krissat; H Perrin; D Azoulay
Journal:  Ann Surg       Date:  1997-12       Impact factor: 12.969

4.  Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines.

Authors:  M Kawada; S Nagamori; H Aizaki; K Fukaya; M Niiya; T Matsuura; H Sujino; S Hasumura; H Yashida; S Mizutani; H Ikenaga
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

5.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

6.  Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation.

Authors:  Charles H Cha; Leyo Ruo; Yuman Fong; William R Jarnagin; Jinru Shia; Leslie H Blumgart; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

Review 7.  Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.

Authors:  T Taguchi
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

Review 8.  Pretreatment neutrophil-lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma.

Authors:  Marc Najjar; Surbhi Agrawal; Jean C Emond; Karim J Halazun
Journal:  J Hepatocell Carcinoma       Date:  2018-01-18

9.  Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.

Authors:  Michał Grąt; Jan Stypułkowski; Waldemar Patkowski; Karolina M Wronka; Emil Bik; Maciej Krasnodębski; Łukasz Masior; Zbigniew Lewandowski; Michał Wasilewicz; Karolina Grąt; Marek Krawczyk; Krzysztof Zieniewicz
Journal:  Ann Surg Oncol       Date:  2017-07-10       Impact factor: 5.344

10.  Hepatic artery chemoembolization for hepatocellular carcinoma recurrence confined to the transplanted liver.

Authors:  Brian I Carr
Journal:  Case Rep Oncol       Date:  2012-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.